Important safety information Prescribing information Healthcare Provider Site
Search
Find a dermatologist

Register for the GALDERMA CARECONNECT CARD

Enter your mobile number below to learn how you may save and get information to help manage your treatment plan

or text SAVE1 TO 86206

care connect

Message & data rates may apply. Message frequency varies. Once registered, text HELP for more info. Text STOP to end.

ABOUT YOUR PRIVACY  |  TERMS AND CONDITIONS

Important Safety Information

Indication: ORACEA® (doxycycline) 40 mg* capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. ORACEA does not lessen the facial redness caused by rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in subjects treated with ORACEA were nasopharyngitis, diarrhea, hypertension and sinusitis. Warnings/Precautions: ORACEA should not be used to treat or prevent infections. ORACEA should not be taken by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA should not be taken during pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years) and may cause reversible inhibition of bone growth. If Clostridium difficile associated diarrhea (CDAD) occurs, may need to discontinue ORACEA. Although photosensitivity was not observed in clinical trials, ORACEA patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of ORACEA treatment beyond 16 weeks and safety beyond 9 months have not been established.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch
or call 1-800-FDA-1088.

*30 mg immediate release and 10 mg delayed release beads

 “With the bumps and blemishes from my rosacea, I thought
I’d never land my dream job”

NOW LOOK AT ME

Not an actual patient
ring
ring ring
Young woman with long red hair and mild rosacea, wearing glasses looking at an iPad next to a work colleague. Not an actual patient.
Not an actual patient

What is rosacea?

Learn about the signs and symptoms of rosacea, how
it differs from acne, and what factors may trigger your
rosacea

What Is rosacea?

ABOUT ORACEA® (DOXYCYCLINE, USP)
40 MG* CAPSULES 

Take back control of the bumps and blemishes of your rosacea!
Learn more about a once-daily treatment

ABOUT ORACEA CAPSULES

ORACEA Capsules are indicated for the treatment of only
inflammatory lesions of rosacea in adult patients

*30 mg immediate release and 10 mg delayed release beads

quote

"Now I finally feel I can help
control my rosacea, I take on
new challenges, and I'm loving it!"

Young woman with long red hair and mild rosacea, smiling at the camera lens with her arms crossed. Not an actual patient.
Not an actual patient
ring

VISITING YOUR DERMATOLOGIST

Get the most out of your appointment

Putting your rosacea into words isn’t always easy. Support your rosacea conversation by personalizing and downloading a discussion guide

Getting the most out of your visit is all part of the journey to help achieve clearer skin

Discussion guide
Not an actual patient
ring ring

YOUR ROSACEA COMMUNITY 

Rosacea Universe

You’re not alone. For ongoing support, tips, and tricks on how to help manage your rosacea symptoms and help you on your journey to achieving clearer skin - make Rosacea Universe your go-to resource. You’ll also find up-to-date information, news, and insights!

ROSACEA UNIVERSE
Oracea Bottle

STAY CONNECTED

Sign up and
stay up-to-date

Sign up here to receive updates and useful information to help better understand your rosacea

subscribe

Important Safety Information

Indication: ORACEA® (doxycycline) 40 mg* capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. ORACEA does not lessen the facial redness caused by rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in subjects treated with ORACEA were nasopharyngitis, diarrhea, hypertension and sinusitis. Warnings/Precautions: ORACEA should not be used to treat or prevent infections. ORACEA should not be taken by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA should not be taken during pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years) and may cause reversible inhibition of bone growth. If Clostridium difficile associated diarrhea (CDAD) occurs, may need to discontinue ORACEA. Although photosensitivity was not observed in clinical trials, ORACEA patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of ORACEA treatment beyond 16 weeks and safety beyond 9 months have not been established.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

*30 mg immediate release and 10 mg delayed release beads

REFERENCES

1. ORACEA [package insert]. Fort Worth, TX: Galderma Laboratories, L.P.; 2014